Firefly Neuroscience (AIFF) Equity Ratio (2010 - 2026)

Firefly Neuroscience's Equity Ratio history runs 16 years deep, the most recent figure standing at 0.77 for Q1 2026.

• In Q1 2026, Equity Ratio rose 84.5% year-over-year to 0.77; the TTM figure through Mar 2026 stood at 0.77 (up 84.5% YoY), while the FY2025 annual figure was 0.73, up 994.35% from the prior year.
• Equity Ratio was 0.77 for Q1 2026 at Firefly Neuroscience, up from 0.73 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.81 in Q2 2025 to a low of 0.52 in Q3 2024.
• Historically, Equity Ratio has averaged 0.26 across 5 years, with a median of 0.33 in 2023.
• The sharpest annual moves came in 2024 and 2025: Equity Ratio sank 297.48% in 2024, then jumped 17643.47% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.28 in 2022, then surged by 114.8% to 0.04 in 2023, then tumbled by 297.48% to 0.08 in 2024, then soared by 994.35% to 0.73 in 2025, then increased by 6.15% to 0.77 in 2026.
• The last three Equity Ratio figures came in at 0.77 (Q1 2026), 0.73 (Q4 2025), and 0.78 (Q3 2025), per Business Quant data.